Insider · CIK 0002032625
Anderman Jonathan
Reports to the SEC for 1 company · BOSTON, MA
Transactions
7
Companies
1
Filings
6
CIK
0002032625
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-04-29 | CMPXCompass Therapeutics, Inc.A Award | +$47.3K |
| 2026-04-29 | CMPXCompass Therapeutics, Inc.P Purchase | +$47.3K |
| 2026-01-02 | CMPXCompass Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-01-02 | CMPXCompass Therapeutics, Inc.A Award | +$776K |
| 2025-04-07 | CMPXCompass Therapeutics, Inc.P Purchase | +$30.8K |
| 2025-02-11 | CMPXCompass Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-08-13 | CMPXCompass Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
Recent filings
- 4/AAnderman Jonathan0001171843-26-002893SEC(opens sec.gov)
- 4Anderman Jonathan0001171843-26-002840SEC(opens sec.gov)
- 4Anderman Jonathan0001171843-26-000051SEC(opens sec.gov)
- 4Anderman Jonathan0001171843-25-002086SEC(opens sec.gov)
- 4Anderman Jonathan0001171843-25-000825SEC(opens sec.gov)
- 4Anderman Jonathan0001171843-24-004782SEC(opens sec.gov)
Companies
Address
C/O COMPASS THERAPEUTICS, INC. 80 GUEST STREET, SUITE 601
BOSTON, MA, 02135